mdl-201112 has been researched along with glucose, (beta-d)-isomer in 1 studies
| Studies (mdl-201112) | Trials (mdl-201112) | Recent Studies (post-2010) (mdl-201112) | Studies (glucose, (beta-d)-isomer) | Trials (glucose, (beta-d)-isomer) | Recent Studies (post-2010) (glucose, (beta-d)-isomer) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 21,956 | 883 | 10,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borcherding, DR; Edwards, CK; Linnik, MD; Long, RE; Parmely, MJ; Watts, LM | 1 |
1 other study(ies) available for mdl-201112 and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Effect of the carbocyclic nucleoside analogue MDL 201,112 on inhibition of interferon-gamma-induced priming of Lewis (LEW/N) rat macrophages for enhanced respiratory burst and MHC class II Ia+ antigen expression.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Bordetella pertussis; Brain; Dipyridamole; Down-Regulation; Female; Histocompatibility Antigens Class II; Interferon-gamma; Kinetics; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mycobacterium tuberculosis; Rats; Rats, Inbred Lew; Receptors, Purinergic P1; Receptors, Purinergic P2; Recombinant Proteins; Respiratory Burst; Stimulation, Chemical; Superoxides; Tumor Necrosis Factor-alpha; Zymosan | 1994 |